Polygenic scores for psychiatric disorders and common diseases

Value of the Information & Strength of the Argument

The lecture provides a comprehensive and well-structured overview of polygenic scores, combining theoretical foundations with practical examples. The argumentation is solid, based on established statistical methods and published studies. The speaker clearly explains the construction of PRS, their interpretation, and their limitations, such as the modest predictive power and the need for large GWAS. The use of concrete examples, such as schizophrenia and coronary artery disease, effectively illustrates the concepts. The lecture also addresses important nuances, such as the difference between relative and absolute risk, and the potential of combining PRS with rare variants. The discussion of applications in psychiatric disorders, including heterogeneity and treatment response, adds depth and relevance.

Scientific Rigor, Source Quality, Title Accuracy

The lecture demonstrates scientific rigor by referencing specific studies and methods, such as the work by Oliver Pain and Alex Gillett on absolute risk conversion, the Australian Genetics of Depression study, and the study by Karmel Choi on exercise and depression. The speaker also mentions the Psychiatric Genomics Consortium and the AMBER study. The title accurately reflects the content, which covers polygenic scores for psychiatric disorders and other common diseases. The lecture is well-structured and the information is presented in a clear and logical manner.

The title accurately reflects the content, which covers polygenic scores for psychiatric disorders and other common diseases.

8/10

Lecture by a professor of genetic epidemiology, based on established methods and published studies, with clear explanation of limitations.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction to polygenic scores and their context in complex disorders.
• 02:00Definition and calculation of polygenic scores from GWAS summary statistics.
• 05:00Distribution of polygenic scores in general population and schizophrenia cases.
• 07:00Relative risk comparisons: top decile vs bottom decile, and top 1% vs rest.
• 09:00Conversion to absolute risk using prevalence and effect size, with R Shiny app.
• 11:00Example of coronary artery disease: PRS stratification and comparison with conventional risk factors.
• 13:00Combining PRS with rare variants: familial hypercholesterolemia and BRCA1/2.
• 15:00PRS in psychiatric disorders: predictive values and heterogeneity in depression.
• 17:00PRS and environmental factors: exercise and depression risk.
• 19:00PRS in first-episode psychosis: discriminating outcomes and diagnosis.
• 21:00PRS in treatment response: antidepressant efficacy and genetic overlap.
• 23:00Current state and future directions: research applications, clinical challenges, and need for cross-ancestry studies.

• R Shiny app for absolute risk conversion — Mentioned as a tool developed by Oliver Pain and Alex Gillett for converting PRS to absolute risk.
• Australian Genetics of Depression study — Study used to illustrate PRS associations with depression heterogeneity.
• Study by Karmel Choi on exercise and depression — Study combining lifestyle and PRS to predict incident depression.
• Psychiatric Genomics Consortium (PGC) — Consortium providing data for GWAS and PRS studies.
• AMBER study on antidepressant response — Study on genetic predictors of antidepressant response.

• Polygenic risk scores in psychiatry — General concept of PRS in psychiatric disorders.
• PRS for coronary artery disease — Example of PRS application in cardiovascular disease.